James Healy - Jan 12, 2023 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role: Director
Signature: /s/ Nathalie Auber, Attorney-in-Fact
Stock symbol: KRTX
Transactions as of: Jan 12, 2023
Transactions value $: -$1,204,771
Form type: 4
Date filed: 1/17/2023, 07:43 PM
Previous filing: Feb 27, 2023
Next filing: Jan 18, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRTX	Common Stock	Other	$0	-300K	-14.48%	$0.00	1.77M	Jan 12, 2023	By Sofinnova Venture Partners X, LP	F2, F3
transaction	KRTX	Common Stock	Other	$0	+6.03K		$0.00	6.03K	Jan 12, 2023	By Sofinnova Management X, L.P.	F4, F5
transaction	KRTX	Common Stock	Sale	-$1.2M	-6.03K	-100%	$199.90	0	Jan 13, 2023	By Sofinnova Management X, L.P.	F5
holding	KRTX	Common Stock						683	Jan 12, 2023	By Sofinnova Synergy Master Fund, LP	F1
holding	KRTX	Common Stock						32.5K	Jan 12, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All shares held by Sofinnova Synergy Master Fund, LP (the "Fund"). Sofinnova Synergy Fund GP, LLC (the "GP"), the general partner of the Fund, may be deemed to have sole voting and dispositive power over these shares, and Dr. James I. Healy and Dr. Eric Delbridge, the managing members of the GP, may be deemed to have shared power to vote and dispose of these shares. Such entities and individuals disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.
F2	Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Sofinnova Venture Partners X, LP ("SVP X") without consideration to its partners in accordance with the limited partnership agreement of SVP X (the "SVP X Distribution").
F3	All shares held by SVP X. Sofinnova Management X, L.P. ("SM X LP"), the general partner of SVP X, may be deemed to have sole voting and dispositive power over these shares, and Sofinnova Management X-A, L.L.C. ("SM X LLC"), the general partner of SM X LP, may be deemed to have sole voting and dispositive power over these shares. Dr. James I. Healy and Dr. Maha Katabi, the managing members of SM X LLC, may be deemed to have shared power to vote and dispose of these shares. Such entities and individuals disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.
F4	Shares acquired by SM X LP in connection with the SVP X Distribution reported above.
F5	All shares held by SM X LP. SM X LLC, the general partner of SM X LP, may be deemed to have sole voting and dispositive power over these shares. Dr. James I. Healy and Dr. Maha Katabi, the managing members of SM X LLC, may be deemed to have shared power to vote and dispose of these shares. Such entities and individuals disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.